TY - JOUR
T1 - Clinical and histological significance of gadolinium enhancement in carotid atherosclerotic plaque
AU - Millon, Antoine
AU - Boussel, Loic
AU - Brevet, Marie
AU - Mathevet, Jean Louis
AU - Canet-Soulas, Emmanuelle
AU - Mory, Cyril
AU - Scoazec, Jean Yves
AU - Douek, Philippe
PY - 2012/11/1
Y1 - 2012/11/1
N2 - Background and Purpose-Although the ability of MRI to investigate carotid plaque composition is well established, the mechanism and the significance of plaque gadolinium (Gd) enhancement remain unknown. We evaluated clinical and histological significance of Gd enhancement of carotid plaque in patients undergoing endarterectomy for carotid stenosis. Methods-Sixty-nine patients scheduled for a carotid endarterectomy prospectively underwent a 3-T MRI. Carotid plaque enhancement was assessed on T1-weighted images performed before and 5 minutes after Gd injection. Enhancement was recorded according to its localization. Histological analysis was performed of the entire plaque and of the area with matched contrast enhancement on MR images. Results-Gd enhancement was observed in 59% patients. Three types of carotid plaques were identified depending on enhancement location (shoulder region, shoulder and fibrous cap, and central in the plaque). Fibrous cap rupture, intraplaque hemorrhage, and plaque Gd enhancement was significantly more frequent in symptomatic than in asymptomatic patients (P=0.043, P<0.0001, and P=0.034, respectively). After histological analysis, Gd enhancement was significantly associated with vulnerable plaque (American Heart Association VI, P=0.006), neovascularization (P<0.0001), macrophages (P=0.030), and loose fibrosis (P<0.0001). Prevalence of neovessels, macrophages, and loose fibrosis in the area of Gd enhancement was 97%, 87%, and 80%, respectively, and was different depending on the enhancement location in the plaque. Fibrous cap status and composition were different depending on the type of plaque. Conclusions-Gd enhancement of carotid plaque is associated with vulnerable plaque phenotypes and related to an inflammatory process.
AB - Background and Purpose-Although the ability of MRI to investigate carotid plaque composition is well established, the mechanism and the significance of plaque gadolinium (Gd) enhancement remain unknown. We evaluated clinical and histological significance of Gd enhancement of carotid plaque in patients undergoing endarterectomy for carotid stenosis. Methods-Sixty-nine patients scheduled for a carotid endarterectomy prospectively underwent a 3-T MRI. Carotid plaque enhancement was assessed on T1-weighted images performed before and 5 minutes after Gd injection. Enhancement was recorded according to its localization. Histological analysis was performed of the entire plaque and of the area with matched contrast enhancement on MR images. Results-Gd enhancement was observed in 59% patients. Three types of carotid plaques were identified depending on enhancement location (shoulder region, shoulder and fibrous cap, and central in the plaque). Fibrous cap rupture, intraplaque hemorrhage, and plaque Gd enhancement was significantly more frequent in symptomatic than in asymptomatic patients (P=0.043, P<0.0001, and P=0.034, respectively). After histological analysis, Gd enhancement was significantly associated with vulnerable plaque (American Heart Association VI, P=0.006), neovascularization (P<0.0001), macrophages (P=0.030), and loose fibrosis (P<0.0001). Prevalence of neovessels, macrophages, and loose fibrosis in the area of Gd enhancement was 97%, 87%, and 80%, respectively, and was different depending on the enhancement location in the plaque. Fibrous cap status and composition were different depending on the type of plaque. Conclusions-Gd enhancement of carotid plaque is associated with vulnerable plaque phenotypes and related to an inflammatory process.
KW - carotid plaque
KW - gadolinium enhancement
KW - high-resolution MRI
KW - plaque vulnerability
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=84868210847&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.112.662692
DO - 10.1161/STROKEAHA.112.662692
M3 - Article
C2 - 22923447
AN - SCOPUS:84868210847
SN - 0039-2499
VL - 43
SP - 3023
EP - 3028
JO - Stroke
JF - Stroke
IS - 11
ER -